{
  "hits": 206,
  "size": 50,
  "data": [
    {
      "title": "泰格医药启动H股上市点评：启动H股上市，国际化加速、管理半径拓展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-12-16 00:00:00.000",
      "infoCode": "AP201912151371851717",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 475,
      "attachPages": 5,
      "encodeUrl": "B1IUQKc/4N20lHq5FMSWcxIM2J+VAE3IE7ZKePgHAoc=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药的临床前业务布局加速，值得关注",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-11-05 00:00:00.000",
      "infoCode": "AP201911051370346356",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 652,
      "attachPages": 5,
      "encodeUrl": "xRjdXmRoB4JPIN4HVn/1DmD5s2qUgS2KU+NDQuUsejE=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "与日本CRO合作深化，关注国际化拓展进度",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-10-31 00:00:00.000",
      "infoCode": "AP201910311370072338",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 737,
      "attachPages": 6,
      "encodeUrl": "h5LOFof/Y2y4Zai40pmxMXgsp0mIN1cob04RPS2AZHw=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "三季报跟踪：收入端增速放缓，无碍长期发展前景",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2019-10-30 00:00:00.000",
      "infoCode": "AP201910301370014980",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000290731.佘宇"
      ],
      "indvIsNew": "001",
      "researcher": "佘宇",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 626,
      "attachPages": 8,
      "encodeUrl": "q6ylz3oO1ogx2N0z8iG/JgiR+XA3kX+pKYoc/5Of6jE=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000290731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "营收持续增长 盈利能力提升",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2019-10-29 00:00:00.000",
      "infoCode": "AP201910291369964718",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 0,
      "reportType": 2,
      "author": [
        "11000182544.魏赟",
        "11000294133.黄施齐"
      ],
      "indvIsNew": "001",
      "researcher": "魏赟,黄施齐",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 403,
      "attachPages": 4,
      "encodeUrl": "IJc/j336KgxqJ26GyV4Fu2ZbOOeve7aOcqy/MubBJEk=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHENZHEN",
      "authorID": [
        "11000182544",
        "11000294133"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Q3单季扣非净利翻倍，业绩持续高增长超预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000200",
      "orgName": "中银国际证券股份有限公司",
      "orgSName": "中银国际",
      "publishDate": "2019-10-28 00:00:00.000",
      "infoCode": "AP201910281369902359",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000258232.张威亚",
        "11000177400.邓周宇"
      ],
      "indvIsNew": "001",
      "researcher": "张威亚,邓周宇",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 510,
      "attachPages": 5,
      "encodeUrl": "wquI0aMUC/Lu9O07WkZN+iYekhctLgXuRcp8Dkpnk3Q=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000258232",
        "11000177400"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年三季报点评：Q3收入端增速略有放缓，利润持续兑现",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2019-10-28 00:00:00.000",
      "infoCode": "AP201910281369857996",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 315,
      "attachPages": 3,
      "encodeUrl": "wquI0aMUC/Lu9O07WkZN+oxkwaJjrviRoITZOd2PxFg=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "主营业务持续高增长，公司业绩符合预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-10-28 00:00:00.000",
      "infoCode": "AP201910281369851672",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 412,
      "attachPages": 3,
      "encodeUrl": "wquI0aMUC/Lu9O07WkZN+lOOe0yXo6YVu9W5VGIEwLk=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHENZHEN",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药2019年三季报预告点评：Q3单季超高增长，多业务拐点趋势或延续",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-10-10 00:00:00.000",
      "infoCode": "AP201910101368387347",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000302632.徐默凡"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,徐默凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 734,
      "attachPages": 5,
      "encodeUrl": "Ewnew4VdkCxLcldc0S1VipSE4DRATd7oFAt9y30mcS4=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000302632"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩维持高速增长 看好临床CRO发展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2019-08-29 00:00:00.000",
      "infoCode": "AP201908291345298378",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000182544.魏赟",
        "11000294133.黄施齐"
      ],
      "indvIsNew": "001",
      "researcher": "魏赟,黄施齐",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 877,
      "attachPages": 4,
      "encodeUrl": "yOgcp2czgtip7q0dS/pIWIRc7y9Q8Vqk5WtPFcBxXdA=",
      "sRatingName": "谨慎增持",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000182544",
        "11000294133"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "半年报跟踪：业绩保持高速增长，看好未来高成长性",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2019-08-29 00:00:00.000",
      "infoCode": "AP201908291345286769",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000290731.佘宇"
      ],
      "indvIsNew": "001",
      "researcher": "佘宇",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 598,
      "attachPages": 9,
      "encodeUrl": "yOgcp2czgtip7q0dS/pIWAqpVESQfeIgWjAs+2WyYQM=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000290731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年半年报点评：咨询业务毛利率大幅提升，期间费用率持续改善",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2019-08-25 00:00:00.000",
      "infoCode": "AP201908251345038967",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 316,
      "attachPages": 3,
      "encodeUrl": "AGC/GakM6GVlFzJSw3P1Z6phdSyLkfDiWKG7HLZ8Fyk=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年中报点评：核心业务高速增长，盈利能力持续提升",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-08-23 00:00:00.000",
      "infoCode": "AP201908231344944218",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1224,
      "attachPages": 4,
      "encodeUrl": "WxDyOrTjVNREPub8n7bDWxfW8Xg+sduY/Q2FGYoUQw0=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "方达上市恢复高增长，公司业绩符合预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-08-23 00:00:00.000",
      "infoCode": "AP201908231344937367",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 421,
      "attachPages": 4,
      "encodeUrl": "WxDyOrTjVNREPub8n7bDW15OUKfQquqy/svKagHkqzU=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHENZHEN",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药2019年中报点评：盈利能力明显提升，业绩持续高增长可期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-08-23 00:00:00.000",
      "infoCode": "AP201908231344932595",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000302632.徐默凡"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,徐默凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 683,
      "attachPages": 5,
      "encodeUrl": "WxDyOrTjVNREPub8n7bDWy7mCDFnsJA2ee4D5A99/V8=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000302632"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：子公司业绩高增长，盈利能力改善",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-08-21 00:00:00.000",
      "infoCode": "AP201908211344799684",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000302632.徐默凡"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,徐默凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 655,
      "attachPages": 5,
      "encodeUrl": "mhD/0HFaqYlEBM6fNAl9Zwrq34Z/6D9X4fgO4gWhVic=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000302632"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：国际多中心能力再拓展，天花板逐步提升",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-08-12 00:00:00.000",
      "infoCode": "AP201908121342932329",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000302632.徐默凡"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,徐默凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 701,
      "attachPages": 6,
      "encodeUrl": "JSn19cu2CDmBsFqglyaO2COPgSe9QXdADwJfwUH/Sj4=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000302632"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "临床CRO快速发展，龙头公司强者恒强",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000200",
      "orgName": "中银国际证券股份有限公司",
      "orgSName": "中银国际",
      "publishDate": "2019-08-08 00:00:00.000",
      "infoCode": "AP201908081342669274",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000258232.张威亚",
        "11000177400.邓周宇"
      ],
      "indvIsNew": "001",
      "researcher": "张威亚,邓周宇",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 913,
      "attachPages": 2,
      "encodeUrl": "KZqKgrker7U7OhFLApypAZVkFWreHg+SWZ2iNPjnTMQ=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000258232",
        "11000177400"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：子公司业绩高弹性，关注一体化平台完善",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-07-31 00:00:00.000",
      "infoCode": "AP201907311341678265",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000302632.徐默凡"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,徐默凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 646,
      "attachPages": 5,
      "encodeUrl": "tJOS5ZhLMv7E9mwF5quZIp1vZYyFnMh5d6MumGjovyE=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000302632"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：战略合作强化，中期意义大于短期业绩影响",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-07-08 00:00:00.000",
      "infoCode": "AP201907081338027174",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000302632.徐默凡"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,徐默凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 652,
      "attachPages": 5,
      "encodeUrl": "y0fy6r3XaoKhN15GIg8+d9hUq60W2YvWP6rHbtBzcwc=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000302632"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：数统实现整合，中美统筹管理提效",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-07-02 00:00:00.000",
      "infoCode": "AP201907021337040042",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000302632.徐默凡"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,徐默凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 647,
      "attachPages": 5,
      "encodeUrl": "uNVNoJ7eNmzd/wsJSo9bKY4qSNF5OvKyvHGdgztCEdo=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000302632"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "方达上市恢复高增长，公司半年报业绩超预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-06-26 00:00:00.000",
      "infoCode": "AP201906261336518052",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 392,
      "attachPages": 3,
      "encodeUrl": "sS4zTzQP39JO52q4nvGp+8XxSAbknW2efvTQ4FbS/qk=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHENZHEN",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：临床业务高景气，驱动公司业绩高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-06-26 00:00:00.000",
      "infoCode": "AP201906261336471985",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 644,
      "attachPages": 5,
      "encodeUrl": "sS4zTzQP39JO52q4nvGp+x/9e9ncD8vWm8Zp4YJGN7I=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：激励方案实施，助推公司国际化拓展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-06-11 00:00:00.000",
      "infoCode": "AP201906111334536007",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 631,
      "attachPages": 5,
      "encodeUrl": "HZcc9h1IV5FT7ahqX3p+4b/PFReCSNCUfW+RZ9+4oIo=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "方达控股完成IPO，资本助力加速产业布局",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-06-03 00:00:00.000",
      "infoCode": "AP201906021333369506",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 472,
      "attachPages": 5,
      "encodeUrl": "VDJ333VUy+04zYWnTxLm5sPGmr4LkKwJI9XKFYX3d7o=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHENZHEN",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药跟踪点评：子公司港交所上市，业务拓展有望加速",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-05-30 00:00:00.000",
      "infoCode": "AP201905301332879023",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 740,
      "attachPages": 5,
      "encodeUrl": "epceNBYX4bsj1UfQUjvR6pGpJ6YtuQht4YQ6fMDN9wQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "深度研究报告：行业持续高景气，临床CRO龙头强者恒强",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000181",
      "orgName": "世纪证券有限责任公司",
      "orgSName": "世纪证券",
      "publishDate": "2019-05-24 00:00:00.000",
      "infoCode": "AP201905241331916856",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3100000000",
      "predictLastYearPe": "53.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000169845.梁希民",
        "11000299735.陈静萱"
      ],
      "indvIsNew": "001",
      "researcher": "梁希民,陈静萱",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1823,
      "attachPages": 31,
      "encodeUrl": "B0p4HjzjPZcbzbXYDK0Z8byVqJNCFccruH9ir0+1YJc=",
      "sRatingName": "增持",
      "sRatingCode": "0103",
      "market": "SHENZHEN",
      "authorID": [
        "11000169845",
        "11000299735"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年报及2019一季报点评：业绩符合预期，全年有望持续高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2019-05-07 00:00:00.000",
      "infoCode": "AP201905071327319703",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000173712.杨若木",
        "11000288631.殷一凡"
      ],
      "indvIsNew": "001",
      "researcher": "杨若木,殷一凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 883,
      "attachPages": 5,
      "encodeUrl": "fgWO3WwGKEPLp2EL+9bQUDSM9s7ZJ/eOPizkJ6QmFoI=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000173712",
        "11000288631"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "年报及一季报跟踪：业绩表现持续亮眼，乘政策东风未来高成长性确定",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2019-05-05 00:00:00.000",
      "infoCode": "AP201905051326640233",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000277542.王晓琦"
      ],
      "indvIsNew": "001",
      "researcher": "王晓琦",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 643,
      "attachPages": 13,
      "encodeUrl": "CoQVNtOv2xRu4mwXGEFmgEOUpPeFWznJnhPBV32X3XY=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000277542"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "咨询服务高速成长，投资收益增厚利润",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2019-04-30 00:00:00.000",
      "infoCode": "AP201904301324638261",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000182544.魏赟",
        "11000294133.黄施齐"
      ],
      "indvIsNew": "001",
      "researcher": "魏赟,黄施齐",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 464,
      "attachPages": 4,
      "encodeUrl": "wWhGS2hbjF4lxj55PfIfYhJMCcFyJT2oNBZQfpJKk7s=",
      "sRatingName": "谨慎增持",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000182544",
        "11000294133"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年年报及2019年一季报点评：业绩持续高增长，国际化进程值得期待",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2019-04-29 00:00:00.000",
      "infoCode": "AP201904291323995629",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 403,
      "attachPages": 3,
      "encodeUrl": "8+pT9dQSGndtSjvioyAY/OSuaZJ8L+/wt4RJ2ijIkTY=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药2018年年报及2019年一季报跟踪：从年报看本土临床CRO的产业路径突围",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-04-29 00:00:00.000",
      "infoCode": "AP201904291323808480",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000262832.袁中平"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,袁中平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1052,
      "attachPages": 6,
      "encodeUrl": "8+pT9dQSGndtSjvioyAY/Nhx4h2d7cmqVST4475Kec0=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000262832"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，主营业务延续高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-04-26 00:00:00.000",
      "infoCode": "AP201904261323316910",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 737,
      "attachPages": 4,
      "encodeUrl": "2GZGhGSTx6ylJlkJsfEAxA6urWDppkL0Q+6tVmb3j7A=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "创新药热潮助飞CRO龙头，员工激励充分维持核心稳定",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-04-10 00:00:00.000",
      "infoCode": "AP201904101317706778",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9500000000",
      "predictLastYearPe": "70.0800000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2230,
      "attachPages": 22,
      "encodeUrl": "9elgCvGE7gHXMwfGMphBZjHyZDndA7FIp1Ud0U0UMQw=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHENZHEN",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "事件点评：Q1业绩延续高增长，股权激励彰显信心",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2019-04-09 00:00:00.000",
      "infoCode": "AP201904091317415673",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9500000000",
      "predictLastYearPe": "66.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000173712.杨若木",
        "11000288631.殷一凡"
      ],
      "indvIsNew": "001",
      "researcher": "杨若木,殷一凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 676,
      "attachPages": 5,
      "encodeUrl": "lrTqS4bKe/rnVIrcOtye5TzuvIAYgx3MM7/QBNqUxp0=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000173712",
        "11000288631"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "主营业务维持高速增长，关注国际化进程",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-04-09 00:00:00.000",
      "infoCode": "AP201904091317213239",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9500000000",
      "predictLastYearPe": "66.4000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 717,
      "attachPages": 4,
      "encodeUrl": "lrTqS4bKe/rnVIrcOtye5UX5LlH4BNhO6MDpYctwBOg=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "一季报预告，主业延续高增长，维持推荐",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-04-09 00:00:00.000",
      "infoCode": "AP201904091317211739",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9500000000",
      "predictLastYearPe": "66.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000262832.袁中平"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,袁中平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 724,
      "attachPages": 5,
      "encodeUrl": "lrTqS4bKe/rnVIrcOtye5S/DuXpcmc8tZHqtOPfXqTw=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000262832"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "增强员工激励，继续布局投资业务",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2019-03-22 00:00:00.000",
      "infoCode": "AP201903221308712139",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9600000000",
      "predictLastYearPe": "66.3000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000278731.方驭涛"
      ],
      "indvIsNew": "001",
      "researcher": "方驭涛",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 459,
      "attachPages": 4,
      "encodeUrl": "t+kPoG3HZ1PV0RZKU8m5bqinEIJl33INfAB0tF1uqk8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000278731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "激励方案助力公司业务及国际化拓展推进",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-03-22 00:00:00.000",
      "infoCode": "AP201903221308662326",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0000000000",
      "predictLastYearPe": "65.8000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000262832.袁中平"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,袁中平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 958,
      "attachPages": 5,
      "encodeUrl": "t+kPoG3HZ1PV0RZKU8m5bvb3qSWj9HZ6IdWzDhqYgLY=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000262832"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药商业模式和发展趋势探讨系列：从数统业务看泰格医药，相比临床更具竞争力的业务",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-03-20 00:00:00.000",
      "infoCode": "AP201903201307662273",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3200000000",
      "predictLastYearPe": "48.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1751,
      "attachPages": 16,
      "encodeUrl": "uTUneSZI0JqJgdb5FyytvtGW/NHunElI3UgBUi0aPko=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药商业模式系列化研究：子公司即将港交所上市，受益于国内仿制药质量升级",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-03-18 00:00:00.000",
      "infoCode": "AP201903181306624104",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3200000000",
      "predictLastYearPe": "45.6000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000262832.袁中平"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,袁中平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1470,
      "attachPages": 19,
      "encodeUrl": "Rk3L/V/ivvLbDZNvarlDPB03h7zMQWF/KZjHf7m20ek=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000262832"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "子公司港交所上市加速，关注国际化进程",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-03-11 00:00:00.000",
      "infoCode": "AP201903111304566445",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0000000000",
      "predictLastYearPe": "62.1000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000262832.袁中平"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,袁中平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 505,
      "attachPages": 5,
      "encodeUrl": "12rxYO08kgk0zi6Lb9IQxwAvHX6l/n/Sd/6Gry3gMrg=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000262832"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "快报符合预期，建议关注数统业务竞争力",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-03-03 00:00:00.000",
      "infoCode": "AP201903031302170573",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9500000000",
      "predictLastYearPe": "54.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 0,
      "reportType": 2,
      "author": [
        "11000262832.袁中平",
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,袁中平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 505,
      "attachPages": 5,
      "encodeUrl": "oGduHaHtlom2XBlokHvUkdAvA+8pwAYdalGNCZ31iRI=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000262832",
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年净利同比增长近6成，创新药发展浪潮中的最大受益者",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券",
      "orgSName": "群益证券",
      "publishDate": "2019-03-01 00:00:00.000",
      "infoCode": "AP201903011301258451",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9500000000",
      "predictLastYearPe": "56.0800000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "64.0000000000",
      "indvAimPriceL": "64.0000000000",
      "attachType": "0",
      "attachSize": 235,
      "attachPages": 2,
      "encodeUrl": "CpvMSYt6BgiUyk2wITRLsRfUUM/KZiKQjtFlysPu7PU=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩基本符合预期，持续保持稳定增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2019-02-28 00:00:00.000",
      "infoCode": "AP201902281301067829",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9600000000",
      "predictLastYearPe": "55.7000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000278731.方驭涛"
      ],
      "indvIsNew": "001",
      "researcher": "方驭涛",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 434,
      "attachPages": 3,
      "encodeUrl": "emR2Pj9Ry4LLZ86sUsjyv/HCFc68SM3vP4f+tzLuFL8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000278731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "关于公司商业模式及未来趋势的探讨：多业务盈利能力释放，确立未来景气度持续",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-02-21 00:00:00.000",
      "infoCode": "AP201902211298932722",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3300000000",
      "predictLastYearPe": "38.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000206140.钟奇",
        "11000262832.袁中平"
      ],
      "indvIsNew": "001",
      "researcher": "钟奇,袁中平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1068,
      "attachPages": 16,
      "encodeUrl": "IAMmH8wyHuXcwBlV6hLpxTii2W7u+Hd8itgVfIhseuo=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000206140",
        "11000262832"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "事件点评：业绩预告符合预期，全年高增长趋势不变",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2019-01-08 00:00:00.000",
      "infoCode": "AP201901071282929422",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "43.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000173712.杨若木",
        "11000288631.殷一凡"
      ],
      "indvIsNew": "001",
      "researcher": "杨若木,殷一凡",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 357,
      "attachPages": 5,
      "encodeUrl": "Ytwk0Xw7iOHZVFQAlkZtkYbKtBQLys9LJupQt4v7Bm8=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000173712",
        "11000288631"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年业绩预告点评：略超市场预期，Q4扣非利润环比大幅提升",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2019-01-04 00:00:00.000",
      "infoCode": "AP201901041282222991",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9400000000",
      "predictLastYearPe": "40.9600000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 400,
      "attachPages": 3,
      "encodeUrl": "W1nF/DH3agNZ5fQrmxOAthjyIAOqjKtcPNZBbBTN5ro=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "CRO龙头，乘国内创新药发展浪潮",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2018-12-20 00:00:00.000",
      "infoCode": "AP201812201274974489",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "49.1800000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "53.0000000000",
      "indvAimPriceL": "53.0000000000",
      "attachType": "0",
      "attachSize": 185,
      "attachPages": 3,
      "encodeUrl": "HEh6VKA5Ekc2S99nMjKU4gZb/Gos4I+7gkzhM0iY6B4=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年员工持股计划点评：员工持股计划推出，彰显公司对业绩信心",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2018-11-14 00:00:00.000",
      "infoCode": "AP201811141244688197",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9400000000",
      "predictLastYearPe": "50.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 345,
      "attachPages": 3,
      "encodeUrl": "Hb1xkibTLGBZP2HcrAdXZXThHRdY2MAFASuq84gS/7w=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    }
  ],
  "TotalPage": 5,
  "pageNo": 3,
  "currentYear": 2025
}